Advertisement SRU Biosystems expands its line of label-free Bind Biosensors - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

SRU Biosystems expands its line of label-free Bind Biosensors

SRU Biosystems, a life science company, has expanded its line of plate-based Bind Biosensors.

SRU Biosystems’s plate-based Bind Biosensor line now includes microplates with the following surfaces: unmodified titanium oxide, surfaces for biochemical applications, streptavidin, and a new line of two extracellular matrix coatings for cell-based assays.

Biosensors are available in 16-, 96-, 384-, 384 low volume- and 1536-well formats, addressing the breadth of throughput requirements. The expansion brings with it optimized performance for biochemical and cell-based applications as well as throughput flexibility, the company said.

Rick Wagner, CEO of SRU Biosystems, said: “SRU has found that the profile of label-free users has diversified to include researchers across academia and industry with an ever-growing list of applications. SRU has focused on building our entire platform, including Bind Readers and Biosensors, to provide superior label-free Bind tools to the widest audience possible.”